Improved Exercise Tolerance and Quality of Life With Cardiac Rehabilitation of Older Patients After Myocardial Infarction

医学 心力衰竭 心肌梗塞 生活质量(医疗保健) 康复 随机对照试验 物理疗法 冲程(发动机) 内科学 护理部 工程类 机械工程
作者
Niccolò Marchionni,Francesco Fattirolli,Stefano Fumagalli,Neil Oldridge,Francesco Del Lungo,Linda Morosi,Costanza Bürgisser,Giulio Masotti
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:107 (17): 2201-2206 被引量:318
标识
DOI:10.1161/01.cir.0000066322.21016.4a
摘要

BACKGROUND: Whether cardiac rehabilitation (CR) is effective in patients older than 75 years, who have been excluded from most trials, remains unclear. We enrolled patients 46 to 86 years old in a randomized trial and assessed the effects of 2 months of post-myocardial infarction (MI) CR on total work capacity (TWC, in kilograms per meter) and health-related quality of life (HRQL). METHODS AND RESULTS: Of 773 screened patients, 270 without cardiac failure, dementia, disability, or contraindications to exercise were randomized to outpatient, hospital-based CR (Hosp-CR), home-based CR (Home-CR), or no CR within 3 predefined age groups (middle-aged, 45 to 65 years; old, 66 to 75 years; and very old, >75 years) of 90 patients each. TWC and HRQL were determined with cycle ergometry and Sickness Impact Profile at baseline, after CR, and 6 and 12 months later. Within each age group, TWC improved with Hosp-CR and Home-CR and was unchanged with no CR. The improvement was similar in middle-aged and old persons but smaller, although still significant, in very old patients. TWC reverted toward baseline by 12 months with Hosp-CR but not with Home-CR. HRQL improved in middle-aged and old CR and control patients but only with CR in very old patients. Complications were similar across treatment and age groups. Costs were lower for Home-CR than for Hosp-CR. CONCLUSIONS: Post-MI Hosp-CR and Home-CR are similarly effective in the short term and improve TWC and HRQL in each age group. However, with lower costs and more prolonged positive effects, Home-CR may be the treatment of choice in low-risk older patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
愈久弥新发布了新的文献求助10
刚刚
我要看文献完成签到 ,获得积分10
刚刚
刻苦的白桃完成签到,获得积分10
刚刚
倘若tt完成签到,获得积分10
1秒前
1秒前
YC发布了新的文献求助10
1秒前
Rosy发布了新的文献求助10
1秒前
青年才俊发布了新的文献求助10
2秒前
不接组会完成签到,获得积分10
2秒前
3秒前
zhangwuhui发布了新的文献求助10
3秒前
Akim的应助被虚拟采纳,获得10
3秒前
3秒前
学术雷锋的应助被黄油小熊采纳,获得10
3秒前
4秒前
王木木发布了新的文献求助10
4秒前
4秒前
4秒前
顾高源发布了新的文献求助20
4秒前
肆先森发布了新的文献求助30
4秒前
Hello的应助被姜姜姜采纳,获得10
6秒前
搞怪的幻巧完成签到,获得积分10
6秒前
6秒前
汉堡包的应助被眉间一把刀采纳,获得10
7秒前
7秒前
7秒前
追寻玉米发布了新的文献求助10
8秒前
8秒前
8秒前
上杉绘梨衣完成签到,获得积分10
8秒前
Charlie完成签到,获得积分10
8秒前
CarryLJR发布了新的文献求助10
8秒前
9秒前
Whr完成签到,获得积分10
9秒前
MST发布了新的文献求助10
9秒前
潇洒热狗完成签到,获得积分10
9秒前
微笑白凝发布了新的文献求助10
10秒前
莫欣宇完成签到 ,获得积分10
10秒前
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Mathematical models in hydrology 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Butadiene hydroxytelechelic oligomers PBHT 500
Ecotourism 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8081979
求助须知:如何正确求助?哪些是违规求助? 9497504
关于积分的说明 21401814
捐赠科研通 7650039
什么是DOI,文献DOI怎么找? 3401714
关于科研通互助平台的介绍 2530853
邀请新用户注册赠送积分活动 2440393